FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038255280> ?p ?o ?g. }

• W2038255280 endingPage "e26515" @default.
• W2038255280 startingPage "e26515" @default.
• W2038255280 abstract "Patients with Malignant Mesothelioma (MM) develop unidentified auto-antibodies to MM tumour antigens. This study was conducted to identify the targets of MM patient auto-antibodies in order to try to understand more of the anti-tumour response and to determine if these antibodies might be helpful for diagnosis or prognostication. Using MM patient sera in a Western immunoblott screening strategy, no common immunoreactive proteins were identified. The sera from one long-term survivor recognised a protein band of 50–60 kDa present in cell lysates from four of five MM cell lines tested. The immunoreactive proteins in this band were identified by 2D electrophoretic separation of a MM cell line protein lysate, followed by analysis of excised immunoreactive proteins on a MALDI TOF mass spectrometer and peptide mass fingerprinting. The immunoreactive proteins identified were vimentin (accession gi55977767) and the ATP synthase (F1-ATPase) beta chain (accession gi114549 and gi47606749). ELISA assays were developed for antibodies to these proteins. Neither vimentin (median and 95% CI 0.346; 0.32–0.468 for MM patients, 0.327; 0.308–0.428 for controls) nor ß-F1-ATPase (0.257; 0.221–0.453 for MM patients, 0.263; 0.22–0.35 for controls) showed significant differences in autoantibody levels between a group of MM patients and controls. Using a dichotomized antibody level (high, low) for these targets we demonstrated that vimentin antibody levels were not associated with survival. In contrast, high ß-F1-ATPase antibody levels were significantly associated with increased median survival (18 months) compared to low ß F1 ATPase antibody levels (9 months; p = 0.049). Immunohistochemical analysis on a MM tissue microarray showed cytoplasmic staining in 28 of 33 samples for vimentin and strong cytoplasmic staining in14 and weak in 16 samples for ß-F1-ATPase. Therefore antibodies to neither vimentin nor ß-F1-ATPase are useful for differential diagnosis of MM, however high antibody levels to ß-F1-ATPase may be associated with increased survival and this warrants further investigation." @default.
• W2038255280 created "2016-06-24" @default.
• W2038255280 creator A5016160844 @default.
• W2038255280 creator A5047815991 @default.
• W2038255280 creator A5051279706 @default.
• W2038255280 creator A5054459274 @default.
• W2038255280 creator A5072802117 @default.
• W2038255280 date "2011-10-17" @default.
• W2038255280 modified "2023-09-23" @default.
• W2038255280 title "Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma" @default.
• W2038255280 cites W1969202046 @default.
• W2038255280 cites W1975745957 @default.
• W2038255280 cites W1981619531 @default.
• W2038255280 cites W1981671675 @default.
• W2038255280 cites W1988857572 @default.
• W2038255280 cites W1994971983 @default.
• W2038255280 cites W1996143418 @default.
• W2038255280 cites W2012274543 @default.
• W2038255280 cites W2014523497 @default.
• W2038255280 cites W2018624539 @default.
• W2038255280 cites W2022843443 @default.
• W2038255280 cites W2025859745 @default.
• W2038255280 cites W2030025965 @default.
• W2038255280 cites W2030128356 @default.
• W2038255280 cites W2037954581 @default.
• W2038255280 cites W2042174530 @default.
• W2038255280 cites W2042973083 @default.
• W2038255280 cites W2068582917 @default.
• W2038255280 cites W2080204163 @default.
• W2038255280 cites W2088502014 @default.
• W2038255280 cites W2098627844 @default.
• W2038255280 cites W2100588878 @default.
• W2038255280 cites W2101534180 @default.
• W2038255280 cites W2108583731 @default.
• W2038255280 cites W2110147320 @default.
• W2038255280 cites W2112984897 @default.
• W2038255280 cites W2117284175 @default.
• W2038255280 cites W2121012812 @default.
• W2038255280 cites W2127303413 @default.
• W2038255280 cites W2131561057 @default.
• W2038255280 cites W2134546050 @default.
• W2038255280 cites W2141178172 @default.
• W2038255280 cites W2147653937 @default.
• W2038255280 cites W2162433324 @default.
• W2038255280 cites W2167410365 @default.
• W2038255280 doi "https://doi.org/10.1371/journal.pone.0026515" @default.
• W2038255280 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3195718" @default.
• W2038255280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22022619" @default.
• W2038255280 hasPublicationYear "2011" @default.
• W2038255280 type Work @default.
• W2038255280 sameAs 2038255280 @default.
• W2038255280 citedByCount "16" @default.
• W2038255280 countsByYear W20382552802013 @default.
• W2038255280 countsByYear W20382552802016 @default.
• W2038255280 countsByYear W20382552802018 @default.
• W2038255280 countsByYear W20382552802019 @default.
• W2038255280 countsByYear W20382552802020 @default.
• W2038255280 countsByYear W20382552802021 @default.
• W2038255280 countsByYear W20382552802022 @default.
• W2038255280 countsByYear W20382552802023 @default.
• W2038255280 crossrefType "journal-article" @default.
• W2038255280 hasAuthorship W2038255280A5016160844 @default.
• W2038255280 hasAuthorship W2038255280A5047815991 @default.
• W2038255280 hasAuthorship W2038255280A5051279706 @default.
• W2038255280 hasAuthorship W2038255280A5054459274 @default.
• W2038255280 hasAuthorship W2038255280A5072802117 @default.
• W2038255280 hasBestOaLocation W20382552801 @default.
• W2038255280 hasConcept C142724271 @default.
• W2038255280 hasConcept C147447768 @default.
• W2038255280 hasConcept C147483822 @default.
• W2038255280 hasConcept C153911025 @default.
• W2038255280 hasConcept C159654299 @default.
• W2038255280 hasConcept C163764329 @default.
• W2038255280 hasConcept C203014093 @default.
• W2038255280 hasConcept C204232928 @default.
• W2038255280 hasConcept C71924100 @default.
• W2038255280 hasConcept C86803240 @default.
• W2038255280 hasConceptScore W2038255280C142724271 @default.
• W2038255280 hasConceptScore W2038255280C147447768 @default.
• W2038255280 hasConceptScore W2038255280C147483822 @default.
• W2038255280 hasConceptScore W2038255280C153911025 @default.
• W2038255280 hasConceptScore W2038255280C159654299 @default.
• W2038255280 hasConceptScore W2038255280C163764329 @default.
• W2038255280 hasConceptScore W2038255280C203014093 @default.
• W2038255280 hasConceptScore W2038255280C204232928 @default.
• W2038255280 hasConceptScore W2038255280C71924100 @default.
• W2038255280 hasConceptScore W2038255280C86803240 @default.
• W2038255280 hasIssue "10" @default.
• W2038255280 hasLocation W20382552801 @default.
• W2038255280 hasLocation W20382552802 @default.
• W2038255280 hasLocation W20382552803 @default.
• W2038255280 hasLocation W20382552804 @default.
• W2038255280 hasLocation W20382552805 @default.
• W2038255280 hasOpenAccess W2038255280 @default.
• W2038255280 hasPrimaryLocation W20382552801 @default.
• W2038255280 hasRelatedWork W1989845789 @default.
• W2038255280 hasRelatedWork W2029559096 @default.
• W2038255280 hasRelatedWork W2074123101 @default.

• next